Favorable-Risk RCC: Factors in Selecting Therapy
Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCCПодробнее
Immunotherapy in Renal Cell CarcinomaПодробнее
Case-Based Tumor Board: Confronting Management Controversies in Renal Cell CarcinomaПодробнее
Selecting Therapy for Poor-Risk Advanced RCCПодробнее
Treating Intermediate and Favorable-Risk Renal Cell CarcinomaПодробнее
Favorable-Risk RCC: Frontline VEGF TKI/IO CombinationsПодробнее
Favorable traits in metastatic RCCПодробнее
Renal Cell Carcinoma: Past, Present, and FutureПодробнее
Prognostic Factors and Treatment Selection in RCCПодробнее
Metastatic RCC: Selecting Therapy at RecurrenceПодробнее
Selecting immunotherapy for RCCПодробнее
Factors Considered When Choosing RCC Treatment OptionsПодробнее
Therapy Selection for Patients With Newly Diagnosed mRCCПодробнее
Advanced RCC Treatment SelectionПодробнее
Adjuvant therapy in RCC: harnessing prognostic informationПодробнее
Advanced, Metastatic Kidney Cancer: Favorable and Very Favorable Risk StratificationПодробнее
Choosing Post-Progression Therapy for Metastatic RCCПодробнее
Advanced RCC: Prognosis and Therapy SelectionПодробнее
Deferred Therapy for Favorable-Risk mRCC PatientsПодробнее